296 related articles for article (PubMed ID: 10780527)
1. Bisphosphonates induce apoptosis in human breast cancer cell lines.
Senaratne SG; Pirianov G; Mansi JL; Arnett TR; Colston KW
Br J Cancer; 2000 Apr; 82(8):1459-68. PubMed ID: 10780527
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates induce breast cancer cell death in vitro.
Fromigue O; Lagneaux L; Body JJ
J Bone Miner Res; 2000 Nov; 15(11):2211-21. PubMed ID: 11092402
[TBL] [Abstract][Full Text] [Related]
3. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
Vorotnjak M; Boos J; Lanvers-Kaminsky C
Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.
Shipman CM; Rogers MJ; Apperley JF; Russell RG; Croucher PI
Br J Haematol; 1997 Sep; 98(3):665-72. PubMed ID: 9332325
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Ziebart T; Pabst A; Klein MO; Kämmerer P; Gauss L; Brüllmann D; Al-Nawas B; Walter C
Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
8. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.
Aparicio A; Gardner A; Tu Y; Savage A; Berenson J; Lichtenstein A
Leukemia; 1998 Feb; 12(2):220-9. PubMed ID: 9519785
[TBL] [Abstract][Full Text] [Related]
9. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
[TBL] [Abstract][Full Text] [Related]
10. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
[TBL] [Abstract][Full Text] [Related]
11. The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.
Senaratne SG; Mansi JL; Colston KW
Br J Cancer; 2002 May; 86(9):1479-86. PubMed ID: 11986784
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in breast cancer.
Coleman RE
Ann Oncol; 2005 May; 16(5):687-95. PubMed ID: 15802276
[TBL] [Abstract][Full Text] [Related]
13. The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.
Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
Anticancer Drugs; 2001 Jun; 12(5):459-65. PubMed ID: 11395574
[TBL] [Abstract][Full Text] [Related]
14. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines.
Xu J; Loo G
J Cell Biochem; 2001 Apr 2-27; 82(1):78-88. PubMed ID: 11400165
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of bisphosphonates on breast cancer cell lines.
Verdijk R; Franke HR; Wolbers F; Vermes I
Cancer Lett; 2007 Feb; 246(1-2):308-12. PubMed ID: 16621245
[TBL] [Abstract][Full Text] [Related]
16. Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.
Dalle Carbonare L; Valenti MT; Bertoldo F; Fracalossi A; Balducci E; Azzarello G; Vinante O; Lo Cascio V
Aging Clin Exp Res; 2007 Apr; 19(2):91-6. PubMed ID: 17446718
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78.
Streitbuerger A; Henrichs M; Ahrens H; Lanvers-Kaminzky C; Gouin F; Gosheger G; Hardes J
Int Orthop; 2011 Sep; 35(9):1369-73. PubMed ID: 20890703
[TBL] [Abstract][Full Text] [Related]
18. The role of bisphosphonates in breast and prostate cancers.
Brown JE; Neville-Webbe H; Coleman RE
Endocr Relat Cancer; 2004 Jun; 11(2):207-24. PubMed ID: 15163299
[TBL] [Abstract][Full Text] [Related]
19. An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting.
Barrett-Lee P; Bloomfield D; Dougherty L; Harries M; Laing R; Patel H; Walker M
Curr Med Res Opin; 2007 Jul; 23(7):1575-82. PubMed ID: 17559749
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines.
Tassone P; Forciniti S; Galea E; Morrone G; Turco MC; Martinelli V; Tagliaferri P; Venuta S
Leukemia; 2000 May; 14(5):841-4. PubMed ID: 10803515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
